NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Short Interest Down 93.3% in April

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totalling 100 shares, a decline of 93.3% from the March 31st total of 1,500 shares. Based on an average daily trading volume, of 7,700 shares, the days-to-cover ratio is presently 0.0 days.

NLS Pharmaceutics Price Performance

Shares of NLS Pharmaceutics stock remained flat at $0.03 during trading on Thursday. The company had a trading volume of 1,000 shares, compared to its average volume of 14,097. NLS Pharmaceutics has a 12-month low of $0.01 and a 12-month high of $0.18. The business’s 50-day simple moving average is $0.05 and its 200 day simple moving average is $0.07.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).